RE:RE:RE:RE:RE:RE:is it possible ?fox7mf wrote: What do you think BP will value a multi ph3 company at? They've certainly overpaid for preclinical biotechs ($2b-$4b usd.) What do you think Onc will go for? If you think below $2b then perhaps you are the dreamer.
Ho we are a multiple ph3 stock... didn't know that!